Untitled

280 EFFECTS OF STRESSLaakmann, G., Hennig, J., Baghai, T., & Schule, C. (2003). Influence of mirtazapine onsalivary cortisol in depressed patients. Neuropsychobiology, 47, 31–36.Laakmann, G., Schule, C., Baghai, T., & Waldvogel, E. (1999). Effects of mirtazapine ongrowth hormone, prolactin, and cortisol secretion in healthy male subjects. Psychoneuroendocrinology,24, 769–784.Lee, P. R., Brady, D., & Koenig, J. I. (2003). Corticosterone alters N-methyl-D-aspartatereceptor subunit mRNA expression before puberty. Molecular Brain Research, 115(1),55–62.Luna, B., & Sweeney, J. A. (2004). The emergence of collaborative brain function: FMRIstudies of the development of response inhibition. Annals of the New York Academy ofSciences, 1021, 296–309.Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P., Thakur, M.,McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998). Cortisol levels during humanaging predict hippocampal atrophy and memory deficits. Nature Neuroscience, 1(1),69–73.Lupien, S. J., Wilkinson, C. W., Briere, S., Menard, C., Ng Ying Kin, N. M., & Nair,N. P. (2002). The modulatory effects of corticosteroids on cognition: Studies in younghuman populations. Psychoneuroendocrinology, 27, 401–416.Markianos, M., Hatzimanolis, J., & Lykouras, L. (1999). Switch from neuroleptics toclozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenicpatients. European Neuropsychopharmacology, 9, 533–536.McGlashan, T. H., Zipursky, R. B., Perkins, D., Addington, J., Miller, T. J., Woods,S. W., Hawkins, K. A., Hoffman, R., Lindborg, S., Tohen, M., & Breier, A. (2003).The PRIME North America randomized double-blind clinical trial of olanzapine versusplacebo in patients at risk of being prodromally symptomatic for psychosis. I. Studyrationale and design. Schizophrenia Research, 61(1), 7–18.McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M.,Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., & Jackson, H. (2002).Randomized controlled trial of interventions designed to reduce the risk of progressionto first-episode psychosis in a clinical sample with subthreshold symptoms. Archivesof General Psychiatry, 59(10), 921–928.Meaney, M. J., Diorio, J., Francis, D., Widdowson, J., LaPlante, P., Caldji, C., Sharma,S., Seckl, J. R., & Plotsky, P. M. (1996). Early environmental regulation of forebrainglucocorticoid receptor gene expression: Implications for adrenocortical responses tostress. Developmental Neuroscience, 18(1–2), 49–72.Meaney, M. J., O’Donnell, D., Rowe, W., Tannenbaum, B., Steverman, A., Walker, M.,Nair, N. P., & Lupien, S. (1995). Individual differences in hypothalamic-pituitaryadrenalactivity in later life and hippocampal aging. Experimental Gerontology, 30(3–4), 229–251.Mesce, K. A. (2002). Metamodulation of the biogenic amines: second-order modulation bysteroid hormones and amine cocktails. Brain, Behavior and Evolution, 60(6), 339–349.Miller, T. J., Zipursky, R. B., Perkins, D., Addington, J., Woods, S. W., Hawkins, K. A.,Hoffman, R., Preda, A., Epstein, I., Addington, D., Lindborg, S., Marquez E., Tohen,M., Breier, A., & McGlashan, T. H. (2003). The PRIME North America randomizeddouble-blind clinical trial of olanzapine versus placebo in patients at risk of beingprodromally symptomatic for psychosis. II. Baseline characteristics of the “prodromal”sample. Schizophrenia Research, 61(1), 19–30.Muck-Seler D., Pivac, N., Mustapic, M., Crncevic, Z., Jokovljevic, M., & Sagud, M. (2004).Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenicwomen. Psychiatry Research, 127(3), 217–226.